SCHEMBL9255106

SCHEMBL9255106

Cn1cc(-c2ccc(C(=O)OCc3ccccc3)cc2C(=N)N)nc1-c1ccc(CCC(=O)OCOC(=O)C(C)(C)C)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
HPGD P15428 2/20 0.36
JMJD6 Q6NYC1 1/20 0.35
DGAT1 O75907 1/20 0.35
MAPT P10636 5/20 0.34
TDP1 Q9NUW8 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
RXRA P19793 1/20 0.33
JAK2 O60674 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.32
TSHR P16473 1/20 0.32
NPY1R P25929 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9255731 0.92 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDJMJD6MAPT
SCHEMBL9247338 0.89 MAPT (0.38) ALDH1A1KDM4EHPGDJMJD6MAPT
SCHEMBL9256887 0.84 ALDH1A1 (0.37) ALDH1A1KDM4EHPGDJMJD6DGAT1
SCHEMBL9253103 0.84 ALOX5 (0.38) ALDH1A1KDM4EHPGDMAPTTDP1
SCHEMBL9281623 0.81 F10 (0.36) MAPTL3MBTL1LMNANPC1RAB9A
SCHEMBL9255100 0.80 KDM4E (0.36) ALDH1A1KDM4EHPGDDGAT1L3MBTL1
SCHEMBL9254434 0.80 KDM4E (0.35) ALDH1A1KDM4EHPGDL3MBTL1RAB9A
SCHEMBL9257107 0.80 F2 (0.37) ALDH1A1HPGDGAARAB9ATSHR
SCHEMBL9257668 0.80 KDM4E (0.36) ALDH1A1KDM4EHPGDMAPTMEN1
SCHEMBL9254562 0.79 PARP1 (0.34) ALDH1A1KDM4EHPGDMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5463071-A Tetrazole derivatives; useful for inhibiting undesirable cell aggregation DR. KARL THOMAE GMBH (DE) 1995-10-31 US disclosed
EP-0525629-A2 5-membered heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-02-03 EP disclosed